Skip to main content
. 2004 Feb 24;90(6):1138–1143. doi: 10.1038/sj.bjc.6601662

Table 3. Five-year relative survival for female breast cancer by TNM stage, age, histology, grade and treatment,a ORCC, 1994–1997.

  TNM stage at diagnosis
  I
II
III
IV
  No RSR (95% CIb) No RSR (95% CI) No RSRSR (95% CI) No RSR (95% CI)
Age (years)                
 0–39 34 91.1 (74.6,97.1) 81 68.6 (55.1,78.8) 13 48.7 (18.5,73.6) 8 28.6 (6.0,57.4)
 40–49 137 92.8 (83.8,96.9) 187 90.0 (82.3,94.5) 45 71.2 (52.5,83.6) 25 33.2 (12.4,55.9)
 50–69 410 97.9 (92.3,99.5) 351 88.6 (82.3,92.7) 56 60.2 (40.6,75.1) 38 27.9 (12.8,45.4)
 70+ 231 94.1 (79.7,98.4) 224 83.2 (71.9,90.2) 41 44.1 (22.3,64.0) 41 17.8 (6.6,33.2)
 
Histologic type
 Ductal carcinoma 687 95.8 (92.0,97.8) 679 85.1 (80.9,88.4) 112 51.4 (38.7,62.7) 69 31.1 (17.8,45.3)
 Lobular carcinoma 81 99.9 85 90.1 (71.8,96.8) 28 89.9 (45.9,98.5) 13
 
Histologic grade
 G1 (well differentiated) 206 98.6 (91.2,99.8) 118 97.4 (75.5,99.8) 11 6
 G2 (mostly differentiated) 296 94.6 (87.8,97.7) 295 87.4 (80.2,92.1) 48 69.7 (48.3,83.6) 17
 G3 (poorly differentiated) 124 90.1 (75.6,96.2) 262 77.6 (69.6,83.7) 43 54.3 (35.1,70.1) 34 20.3 (4.5,43.9)
 
Treatment
 Chemotherapy 2 12 62.2 (25.7,84.7) 4 12
 Radiotherapy 36 93.7 (70.9,98.8) 8 73.1 (25.5,93.1) 2 2
 Surgery 100 90.7 (75.1,96.7) 46 85.9 (55.2,96.2) 2 2
 C+Rc 18 93.2 (46.8,99.3) 46 75.0 (57.6,86.1) 28 57.6 (32.8,76.2) 29 9.0 (1.5,25.0)
 C+Sc 89 82.3 (68.6,90.5) 204 86.2 (77.3,91.8) 14 69.9 (24.6,91.2) 26 27.9 (9.6,49.8)
 R+Sc 314 97.1 (89.8,99.2) 40 93.4 (49.9,99.3) 3 2
 C+R+Sc 247 92.8 (85.9,96.4) 482 80.6 (75.0,85.0) 101 53.0 (39.3,64.9) 36 21.9 (8.7,38.9)
a

—=rate not reported. No. of cases less than 20 except for age; RSR=relative survival rate.

b

CI=confidence interval.

c

C=chemotherapy; R=radiotherapy; S=surgery.